These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14405590)

  • 1. [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].
    HUSMANN KH
    Z Hyg Infektionskr; 1959; 146():89-96. PubMed ID: 14405590
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):339-48. PubMed ID: 13539378
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the inactivation of phage by the properdin system. II. Quantitative assay of phage-neutralizing activity.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):349-55. PubMed ID: 13539379
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the phage-neutralizing activity of the properdin system in the blood of cancer patients treated with conventional radiotherapy, Clinico-experimental research].
    PAOLINI FA
    Minerva Med; 1961 Apr; 52():1346-52. PubMed ID: 13732561
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of properdin in the first days of life. Study by bacteriophage neutralization].
    CONCA G
    Minerva Pediatr; 1959 Sep; 11():992-6. PubMed ID: 13811458
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 7. Interference by endotoxic polysaccharides with inactivation of coliphage by human serum.
    LANDY M; TRAPANI RJ; SHEAR MJ
    Br J Exp Pathol; 1958 Dec; 39(6):618-30. PubMed ID: 13607920
    [No Abstract]   [Full Text] [Related]  

  • 8. [The inhibitory activity of serum against T2r + bacteriophage in relation to properdin].
    FRANCQ JC; EYQUEM A; GUYOTJEANNIN N
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):178-83. PubMed ID: 13627583
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antibacteriophage power of the blood considered as an index of properdin activity in patients of pulmonary tuberculosis].
    BASILICO F; RIMOLDI R; GRASSI F
    G Ital Tuberc Mal Torace; 1961; 15():5-6. PubMed ID: 13687595
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpretation of properdin levels determined by phage neutralization technique.
    COWAN KM
    Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of the phage-neutralizing property in the blood of newborn infants and of mothers of the properdin system as a method of evaluating the latter.
    CARLETTI B
    Minerva Pediatr; 1959 Jun; 11(25-26):706-7. PubMed ID: 13674297
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Observations on the determination of properdin by means of bacteriophage neutralization].
    PERNIS B; TURRI M
    Boll Ist Sieroter Milan; 1958; 37(9-10):414-24. PubMed ID: 13607654
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
    SEKIGUCHI M
    Arerugi; 1963; 12():348-57. PubMed ID: 14095328
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "properdin system" and some stomatological diseases. VI. Relation between the serum properdin titer and malignant epithelial neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():657-9. PubMed ID: 14480071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interference of polysaccharides of meconium on the properdin system. Experimental contribution].
    SAGONE I
    Ann Ostet Ginecol; 1960 Feb; 82():191-6. PubMed ID: 14440777
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
    van den Bogaard R; Fijen CA; Schipper MG; de Galan L; Kuijper EJ; Mannens MM
    Eur J Hum Genet; 2000 Jul; 8(7):513-8. PubMed ID: 10909851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.